These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3223158)

  • 61. [ON THE INTERPRETATION OF A FINDING OF SINO-ATRIAL BLOCK IN A CASE OF MYOTONIC DYSTROPHY].
    PALMA P; COSTERO A
    Boll Soc Ital Cardiol; 1963; 8():247-53. PubMed ID: 14119259
    [No Abstract]   [Full Text] [Related]  

  • 62. Wide QRS Complex Tachycardia After Atropine Eye Drop Instillation as the First Manifestation of Steinert Disease.
    Olmedo Llanes J; López Salguero R; Ruiz Serrato A; Cordero Aguilar A
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):401-402. PubMed ID: 27843001
    [No Abstract]   [Full Text] [Related]  

  • 63. The quantification of myotonia. A problem in the evaluation of new antimyotonic drugs.
    Durelli L; Mutani R; Piredda S; Fassio F; Delsedime M
    J Neurol Sci; 1983 May; 59(2):167-73. PubMed ID: 6854347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Experience in the multi-modal therapy of acne, including volcano mud applications and cosmetic procedures].
    Israfilova FG
    Vestn Dermatol Venerol; 1989; (2):56-7. PubMed ID: 2524938
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Study of medical practices for patients with myotonic dystrophy in Japan-Nationwide specialist survey].
    Matsumura T; Takada H; Ishigaki K; Komaki H; Takahashi MP
    Rinsho Shinkeigaku; 2020 Feb; 60(2):120-129. PubMed ID: 31956155
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanisms and management of the heart in myotonic dystrophy.
    McNally EM; Sparano D
    Heart; 2011 Jul; 97(13):1094-100. PubMed ID: 21642660
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cortisone therapy of myotonic dystrophy].
    ZAPPI F
    Riv Neurol; 1955; 25(1):141-4. PubMed ID: 13246539
    [No Abstract]   [Full Text] [Related]  

  • 68. 2010 Marigold therapeutic strategies for myotonic dystrophy.
    Blonsky K; Monckton D; Wieringa B; Schoser B; Day JW; Engelen Bv
    Neuromuscul Disord; 2012 Jan; 22(1):87-94. PubMed ID: 21852134
    [No Abstract]   [Full Text] [Related]  

  • 69. Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop: Clearwater, Florida, November 30, 2011.
    Gagnon C; Meola G; Hébert LJ; Puymirat J; Laberge L; Leone M
    Neuromuscul Disord; 2013 Dec; 23(12):1056-68. PubMed ID: 24011704
    [No Abstract]   [Full Text] [Related]  

  • 70. Procaine amide in the treatment of myotonia.
    GESCHWIND N; SIMPSON JA
    Brain; 1955; 78(1):81-91. PubMed ID: 14378451
    [No Abstract]   [Full Text] [Related]  

  • 71. Gait abnormalities in type 1 myotonic muscular dystrophy: 3D motion analysis, energy cost and surface EMG.
    Tiffreau V; Detrembleur C; Van Den Bergh P; Renders A; Kinet V; Lejeune T
    Comput Methods Biomech Biomed Engin; 2012; 15 Suppl 1():171-2. PubMed ID: 23009467
    [No Abstract]   [Full Text] [Related]  

  • 72. Electromyography in myotonic dystrophy.
    Streib E; Sun SF
    Ann Neurol; 1983 Feb; 13(2):218-9. PubMed ID: 6830190
    [No Abstract]   [Full Text] [Related]  

  • 73. [Peloid therapy: the theoretical and practical aspects, problems and prospects of its development].
    Badalov NG; Krikorova SA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (3):50-4. PubMed ID: 23113372
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Did You Examine the Parents?
    Banerjee A; Sharawat IK; Saini AG; Suthar R
    J Pediatr; 2019 Feb; 205():286. PubMed ID: 30322702
    [No Abstract]   [Full Text] [Related]  

  • 75. Diagnosis and Management of Myotonic Dystrophy Type 1.
    Hartman J; Patki T; Johnson NE
    JAMA; 2024 Apr; 331(14):1227-1228. PubMed ID: 38466298
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Unusual aspects of the effect of methylandrostenediol therapy of nitrogen metabolism in myotonia dystrophica].
    HORANYI M; HOLLO I; BEKENY G
    Magy Belorv Arch Ideggyogy Szle; 1954 Feb; 7(1):15-20. PubMed ID: 13213256
    [No Abstract]   [Full Text] [Related]  

  • 77. Atrial electromechanical coupling parameters should be kept in mind during the assessment of atrial arrhythmia risk.
    Yiginer O; Tokatli A; Gokhan D; Dogan M
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):3989-90. PubMed ID: 26592816
    [No Abstract]   [Full Text] [Related]  

  • 78. Therapy of myotonia. Electromyographic evaluation of acute effects of taurine.
    Durelli L; Fassio F; Piredda S; Mutani R
    Ital J Neurol Sci; 1981 May; 2(2):185-7. PubMed ID: 7333819
    [No Abstract]   [Full Text] [Related]  

  • 79. Therapeutic effects of ACTH in myotonia dystrophica.
    REESE HH; PETERS HA
    Dis Nerv Syst; 1952 Apr; 13(4):99-105. PubMed ID: 14916769
    [No Abstract]   [Full Text] [Related]  

  • 80. MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011.
    Turner C; Hilton-Jones D; Lochmüller H; Hanna MG
    Neuromuscul Disord; 2013 Dec; 23(12):1069-80. PubMed ID: 24054840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.